NCCPF No:- 102096
Catalogue Information : |
|||||
| Candida | glabrata | ||||
| 102096 | |||||
Senders Details : |
|||||
| pgimer | NA | ||||
| NA | |||||
| Blood | |||||
| 709 | |||||
MALDI Based Identification : |
|||||
| candida glabrata | 99.9 Biomereux | ||||
VITEK Based Identification : |
|||||
DNA Sequencing Based Identification : |
|||||
| Candida glabrata | ITS | ||||
| 100% | 27-Sep-2022 | ||||
| 1665402908_102096_1.pdf | 102096 | ||||
| 102096 | |||||
ANTIFUNGAL SUSCEPTIBILITY TESTING (AFST) CLSI METHOD : |
|||||
| Yeast | Candida | ||||
| candida glabrata | |||||
| 1 | posaconazole | 0.125 | Sensitive | ||
| 2 | Micafungin | 0.060 | Sensitive | ||
| 3 | Fluconazole | 32.000 | Resistant | ||
| 4 | Voriconazole | 0.060 | Sensitive | ||
| 5 | Itraconazole | 0.250 | Sensitive | ||
| 6 | Caspofungin | 0.500 | Sensitive | ||
| 7 | Anindulifungin | 0.030 | Sensitive | ||
| 8 | Amphotericin B | 1.000 | Sensitive | ||